<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          USEUROPEAFRICAASIA 中文雙語Fran?ais
          China
          Home / China / China

          Interest in TCM growing globally

          By Shan Juan | China Daily | Updated: 2013-03-27 07:14

          Chinese mainland accounts for 2% of herbal medicine sales worldwide

          While some Chinese scholars propose abolishing traditional Chinese medicine, foreign pharmaceutical institutions and industries are pursuing them.

          More than 100 countries and regions around the world have set up TCM institutions, with the United States, Europe, Japan and South Korea investing heavily in related research and medication development, industry, analyses show.

          The UK-based pharmaceutical company GlaxoSmithKline PLC announced its first TCM medication research and development program, which targets not just the Chinese market, but the global one as well.

          "TCM is a well-established medical science based on thousands of years of clinical practices. It shows great promise treating complicated conditions that the single-target Western medicine has failed to handle," said Zang Jingwu, senior vice-president and head of GlaxoSmithKline's R&D in China.

          "Our priority is to transform TCM from an experience-based practice to evidence-based medicines through innovation and differentiation," he said.

          Currently, a 10-person team in Shanghai is in charge of the program, with a medication candidate for skin disease in the works.

          Zang, a US-trained neurologist, said TCM is more of a multi-target therapeutical approach, which might work to treat complex conditions.

          He said an example of this is ginkgo biloba leaf extract, approved in Germany, which, according to China's pharmacopeia, is TCM in essence. Globally, ginkgo biloba leaf extract is widely used to treat dizziness and ringing in the ears.

          Industry insiders call such products "exotic TCM". In ancient TCM works, ginkgo is known for restoring consciousness.

          "That is similar to our approach in TCM R&D," he said. He referred to skin diseases for which medications can demonstrate more evidence of effectiveness as a top candidate for TCM. Other areas of research that also show great promise include stomach and intestinal diseases and supplementary treatments for cancer, he added.

          However, given that the culture and ideology of TCM is different from that of Western medicine, great innovation is required to integrate the two sciences, he said.

          "In fact, many in Western medicine circles have recognized the importance of TCM, but the problem is how to prove and develop that," said Huang Jianyin, deputy secretary-general of the World Federation of Chinese Medicine Societies.

          TCM is developed through empirical testing and refinement of herbal mixtures and relies on clinical experience, and many in the West don't trust that, he said. TCM, particularly herbal products, are largely available in the US and Europe, but questions like how to prove their effectiveness in the context of Western medicine and how to best use them remain unanswered, Zang added.

          Zhang Lingping, director of the international cooperation department of the Beijing University of Chinese Medicine, welcomed the emerging trend.

          "Their increasing interest shows Western medicine circles have begun to learn about the time-honored medical science, which originated in China," she said. Zhang said traditionally, Western medicines have been highly targeted and such a method doesn't seem to work well for complex diseases.

          "They are beginning to closely look at TCM, which highlights a natural and comprehensive manner in healing," she said.

          The university also had partnerships with foreign academic institutions in TCM research focusing on cancer and cardio-cerebrovascular diseases.

          A better approach for TCM development is to enhance its dosage and stability, she said.

          "It's more feasible and practical for them to improve the techniques during the TCM production, which the multinational pharmaceutical giants are better at," she said.

          But that might also pose a challenge for domestic TCM industries, she acknowledged.

          Of the global herbal medicine sales volume, the Chinese mainland accounted for only 2 percent, industry analyses show. Japan has the share of the market at 90 percent.

          Mao Zedong once expected TCM and Chinese cuisine would be China's two major contributions to the world, said Huang. "He wouldn't have imagined the tough situation today."

          shanjuan@chinadaily.com.cn

          Editor's picks
          Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          主站蜘蛛池模板: 成人午夜av在线播放| 视频一区无码中出在线| 老司机性色福利精品视频| 日韩一区二区三区日韩精品| 国产成人精品一区二区三| 小污女小欲女导航| 91精品久久久久久无码人妻| 亚洲人成网站在线观看播放不卡| 国产又爽又黄又不遮挡视频| 欧美大bbbb流白水| 日本九州不卡久久精品一区 | 亚洲色拍拍噜噜噜最新网站| 国产精品成人午夜福利| 亚洲精品第一区二区三区| 精品伊人久久久大香线蕉欧美| 亚洲伊人成色综合网| 国内精品久久久久久久影视麻豆| 国产色无码专区在线观看| 动漫精品中文字幕无码| 无码精品人妻一区二区三区中 | 国内熟妇人妻色在线视频| 日韩深夜福利视频在线观看| 任我爽精品视频在线播放| 国产亚洲精品久久久久久无亚洲 | 亚洲精品国产精品国在线| 欧美喷潮最猛视频| 亚洲一区二区三区自拍麻豆| 精品国产欧美一区二区三区在线| 青草热在线观看精品视频| 久久香蕉国产线看观看亚洲片| 影音先锋大黄瓜视频| 人人人爽人人爽人人av| 中文字幕在线日韩一区| yyyy在线在片| 一级毛片在线观看免费| 成人网站免费观看永久视频下载| 天堂网亚洲综合在线| 日韩少妇人妻vs中文字幕| 蜜桃mv在线播放免费观看视频| 国产精品中文一区二区| 四虎国产精品永久在线|